BRAF and cancer: We examined a cohort of BRAF‐wild‐type cancers and BRAF‐mutant cancers, further stratified by microsatellite instability status (Fig. 4C), and found KLF5 to be significantly elevated in BRAF‐mutant cancers (Fig. 4D).